Trending NewsTrending NewsNASDAQ:TEM Tempus AI (TEM) Stock Price, News & Analysis $58.29 -3.71 (-5.98%) Closing price 04:00 PM EasternExtended Trading$58.38 +0.09 (+0.16%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Tempus AI Stock (NASDAQ:TEM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Tempus AI alerts:Sign Up Key Stats Today's Range$57.86▼$61.2950-Day Range$53.20▼$72.0052-Week Range$31.36▼$91.45Volume9.13 million shsAverage Volume8.44 million shsMarket Capitalization$10.09 billionP/E RatioN/ADividend YieldN/APrice Target$65.09Consensus RatingModerate Buy Company Overview Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. Read More Tempus AI Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks49th Percentile Overall ScoreTEM MarketRank™: Tempus AI scored higher than 49% of companies evaluated by MarketBeat, and ranked 582nd out of 935 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingTempus AI has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 6 buy ratings, 6 hold ratings, and no sell ratings.Amount of Analyst CoverageTempus AI has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Tempus AI's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Tempus AI are expected to grow in the coming year, from ($6.15) to ($1.33) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Tempus AI is -7.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Tempus AI is -7.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTempus AI has a P/B Ratio of 166.54. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Tempus AI's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted24.50% of the float of Tempus AI has been sold short.Short Interest Ratio / Days to CoverTempus AI has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Tempus AI has recently increased by 12.39%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTempus AI does not currently pay a dividend.Dividend GrowthTempus AI does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted24.50% of the float of Tempus AI has been sold short.Short Interest Ratio / Days to CoverTempus AI has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Tempus AI has recently increased by 12.39%, indicating that investor sentiment is decreasing significantly. News and Social Media2.6 / 5News Sentiment0.65 News SentimentTempus AI has a news sentiment score of 0.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.07 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 36 news articles for Tempus AI this week, compared to 19 articles on an average week.Search InterestOnly 99 people have searched for TEM on MarketBeat in the last 30 days. This is a decrease of -9% compared to the previous 30 days.MarketBeat Follows61 people have added Tempus AI to their MarketBeat watchlist in the last 30 days. This is an increase of 30% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Tempus AI insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $41,600,238.00 in company stock.Percentage Held by Insiders27.60% of the stock of Tempus AI is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 24.22% of the stock of Tempus AI is held by institutions.Read more about Tempus AI's insider trading history. Receive TEM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tempus AI and its competitors with MarketBeat's FREE daily newsletter. Email Address TEM Stock News HeadlinesTempus AI, Inc. (NASDAQ:TEM) COO Sells $300,000.00 in StockJuly 10, 2025 | insidertrades.comTEMPUS AI SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Tempus AI, Inc. - TEM1 hour ago | globenewswire.comThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important updates you'll ever see. A new initiative, linked to President Trump's Executive Order #14196, has the potential to do more than just protect Social Security from collapse... According to renowned investor Louis Navellier, it could increase benefits by as much as 400%.July 29 at 2:00 AM | InvestorPlace (Ad)INVESTOR NOTICE: Tempus AI, Inc. (TEM) Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJuly 29 at 4:18 PM | prnewswire.comTEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJuly 29 at 4:00 PM | globenewswire.comTempus AI: Sustaining Growth Momentum With Acquisitions & PartnershipsJuly 29 at 10:06 AM | seekingalpha.comTempus AI (TEM) Secures FDA Clearance For ECG-Low EF SoftwareJuly 29 at 2:07 AM | finance.yahoo.comBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vestis and Tempus and Encourages Investors to Contact the FirmJuly 28 at 7:13 PM | globenewswire.comSee More Headlines TEM Stock Analysis - Frequently Asked Questions How have TEM shares performed this year? Tempus AI's stock was trading at $33.76 at the start of the year. Since then, TEM shares have increased by 72.7% and is now trading at $58.29. How were Tempus AI's earnings last quarter? Tempus AI, Inc. (NASDAQ:TEM) released its quarterly earnings data on Tuesday, May, 6th. The company reported ($0.24) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.03. The business's quarterly revenue was up 75.4% on a year-over-year basis. Read the conference call transcript. When did Tempus AI IPO? Tempus AI (TEM) raised $411 million in an initial public offering (IPO) on Friday, June 14th 2024. The company issued 11,100,000 shares at $37.00 per share. Who are Tempus AI's major shareholders? Tempus AI's top institutional shareholders include Aberdeen Group plc (0.12%), CWM LLC (0.11%), Exchange Traded Concepts LLC (0.05%) and Clarity Capital Partners LLC (0.05%). Insiders that own company stock include Bradley A Keywell, Eric P Lefkofsky, James William Rogers, Ryan Fukushima, Andrew Polovin, Erik Phelps, Ryan M Bartolucci, Nadja West, Jennifer A Doudna and David R Epstein. View institutional ownership trends. How do I buy shares of Tempus AI? Shares of TEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Tempus AI own? Based on aggregate information from My MarketBeat watchlists, some other companies that Tempus AI investors own include AST SpaceMobile (ASTS), NVIDIA (NVDA), Broadcom (AVGO), Micron Technology (MU), Recursion Pharmaceuticals (RXRX), Genius Sports (GENI) and Super Micro Computer (SMCI). Company Calendar Last Earnings5/06/2025Today7/29/2025Next Earnings (Confirmed)8/08/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryComputer Software Current SymbolNASDAQ:TEM Previous SymbolNASDAQ:TEM CIK1717115 Webwww.tempus.com Phone800-976-5448FaxN/AEmployees2,400Year FoundedN/APrice Target and Rating Average Price Target for Tempus AI$65.09 High Price Target$75.00 Low Price Target$52.00 Potential Upside/Downside+11.7%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage12 Analysts Profitability EPS (Trailing Twelve Months)($7.80) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$705.81 million Net Margins-88.27% Pretax Margin-93.23% Return on Equity-533.21% Return on Assets-66.19% Debt Debt-to-Equity Ratio2.45 Current Ratio1.71 Quick Ratio1.56 Sales & Book Value Annual Sales$693.40 million Price / Sales14.55 Cash FlowN/A Price / Cash FlowN/A Book Value$0.35 per share Price / Book166.54Miscellaneous Outstanding Shares173,120,000Free Float125,336,000Market Cap$10.09 billion OptionableN/A BetaN/A Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:TEM) was last updated on 7/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tempus AI, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tempus AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.